TSPAN: A Non-Specified Subtype of Sprouting Angiogenesis Factor
TSPAN: A Non-Specified Subtype of Sprouting Angiogenesis Factor
Tetraspanin (TSPAN) is a protein that is expressed in various cell types in the human body. It is a member of the sprouting angiogenesis factor (SF) family, which is known for promoting the formation of new blood vessels. TSPAN is a non-specified subtype of this protein, meaning that it lacks specific sequences that are unique to a particular subtype.
One of the unique features of TSPAN is its role in cell signaling. It is a negative regulator of the Notch signaling pathway, which is a well-known pathway that is involved in the development and maintenance of tissues. TSPAN plays a crucial role in the regulation of Notch signaling by negativeizing the activity of the Notch receptor, which is a protein that is expressed in many different cell types.
TSPAN is also involved in the regulation of cell adhesion. It is a negative regulator of the cadherin adhesion molecule, which is a protein that is involved in the formation of tight junctions between cells. TSPAN works by binding to the cadherin receptor and inhibiting its activity. This interaction between TSPAN and cadherin is important for the regulation of cell behavior, such as cell division, migration, and invasion.
In addition to its role in cell signaling and cell adhesion, TSPAN is also involved in the regulation of angiogenesis. It is a positive regulator of the vascular endothelial growth factor (VEGF), which is a protein that is involved in the formation of new blood vessels. TSPAN works by binding to the VEGF receptor and promoting its activity. This interaction between TSPAN and VEGF is important for the formation of new blood vessels, which is a critical process for the development of new tissues and organs.
TSPAN is also a potential drug target in the treatment of various diseases. One of the main targets for TSPAN is the treatment of cancer. Cancer is a disease that is characterized by the formation of new blood vessels, which can contribute to the growth and survival of cancer cells. TSPAN is involved in the regulation of cancer cell growth and angiogenesis, which makes it an attractive target for cancer treatments.
Another potential target for TSPAN is the treatment of cardiovascular disease. TSPAN is involved in the regulation of blood vessel formation and function, which is important for the proper functioning of the cardiovascular system. TSPAN is also involved in the regulation of the expression of genes that are involved in cardiovascular disease, such as those that encode for blood clotting factors. This makes TSPAN an attractive target for the treatment of cardiovascular disease.
In conclusion, TSPAN is a non-specified subtype of the sprouting angiogenesis factor (SF) family that is involved in the regulation of cell signaling, cell adhesion, and angiogenesis. It is a potential drug target for the treatment of various diseases, including cancer and cardiovascular disease. Further research is needed to fully understand the role of TSPAN in these processes and to develop effective treatments.
Protein Name: Tetraspanin (nonspecified Subtype)
The "Tetraspanin Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about Tetraspanin comprehensively, including but not limited to:
• general information;
• protein structure and compound binding;
• protein biological mechanisms;
• its importance;
• the target screening and validation;
• expression level;
• disease relevance;
• drug resistance;
• related combination drugs;
• pharmacochemistry experiments;
• related patent analysis;
• advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai
More Common Targets
TEX10 | TEX101 | TEX11 | TEX12 | TEX13A | TEX13B | TEX13C | TEX14 | TEX15 | TEX19 | TEX2 | TEX21P | TEX22 | TEX26 | TEX261 | TEX264 | TEX28 | TEX29 | TEX30 | TEX33 | TEX35 | TEX36 | TEX36-AS1 | TEX37 | TEX38 | TEX41 | TEX43 | TEX44 | TEX45 | TEX46 | TEX47 | TEX48 | TEX49 | TEX50 | TEX52 | TEX53 | TEX55 | TEX56P | TEX9 | TF | TFAM | TFAMP1 | TFAP2A | TFAP2A-AS1 | TFAP2A-AS2 | TFAP2B | TFAP2C | TFAP2D | TFAP2E | TFAP4 | TFB1M | TFB2M | TFCP2 | TFCP2L1 | TFDP1 | TFDP1P2 | TFDP2 | TFDP3 | TFE3 | TFEB | TFEC | TFF1 | TFF2 | TFF3 | TFG | TFIID Basal Transcription Factor Complex | TFIIIC2 complex | TFIP11 | TFIP11-DT | TFPI | TFPI2 | TFPT | TFR2 | TFRC | TG | TGDS | TGFA | TGFA-IT1 | TGFB1 | TGFB1I1 | TGFB2 | TGFB2-AS1 | TGFB3 | TGFBI | TGFBR1 | TGFBR2 | TGFBR3 | TGFBR3L | TGFBRAP1 | TGIF1 | TGIF2 | TGIF2-RAB5IF | TGIF2LX | TGIF2LY | TGM1 | TGM2 | TGM3 | TGM4 | TGM5 | TGM6
